The Scientific & Research Team at KSQ Therapeutics leverages the company's proprietary CRISPRomics platform to conduct high-throughput, genome-scale functional genomics studies. Their work involves identifying and validating critical genetic targets that correlate with disease mechanisms, with the aim of accelerating the discovery and development of innovative therapeutic solutions. This interdisciplinary team includes experts in clinical sciences, discovery biology, computational biology, data science, and cell therapy, all collaborating to translate genomic data into actionable therapeutic strategies.
Andrew Wylie
SVP, Discovery Biology
Anne Dodson
Associate Principal Scientist,...
Chris Middleton
Associate Principal Scientist,...
Frank Thompson
Senior Associate Scientist
Maria Torres-Castill...
Associate Principal Scientist
Meghan Travers
Senior Scientist, Cell Therapy
Micah Benson
Chief Scientific Officer
Morgan Murray
Senior Associate Scientist
Patty Martins Harris
SVP, Clinical Sciences
View all